期刊文献+

高血压病人健康子女胰岛素抵抗与AngⅡ及降钙素基因相关肽变化 被引量:4

CHANGES OF IR,PLASMA AngⅡ AND CGRP IN HEALTHY CHILDREN WITH FAMILY HISTORY OF ESSENTIAL HYPERTENSION
下载PDF
导出
摘要 目的检测原发性高血压(EH)病人之健康子女的胰岛素抵抗(IR)、血浆血管紧张素Ⅱ(AngⅡ)及降钙素基因相关肽(CGRP)的变化,探讨其在高血压发病机制中的作用以及在高血压一级预防中的意义。方法随机选择60例具有高血压家族史的健康子女,其中父亲或母亲一方患高血压的健康子女30例为单亲组,双亲均患高血压的健康子女30例为双亲组,无高血压家族史的健康子女30例为对照组。用放免法测定空腹血浆胰岛素(FINS)、AngⅡ和CGRP的含量,计算胰岛素抵抗指数(IRI)。结果双亲组和单亲组IRI、血浆AngⅡ及CGRP含量均高于对照组,差异具有显著性(F=14.43~16.63,q=6.48~8.15,P<0.01);双亲组血浆AngⅡ和CGRP含量高于单亲组,差异有统计学意义(F=15.14、16.63,q=3.12、3.98,P<0.05)。两研究组血浆AngⅡ与CGRP含量呈正相关(r=0.682,P<0.01)。结论具有高血压家族史的健康子女在血压升高之前已经存在IR等代谢改变,血浆AngⅡ及CGRP等血管活性物质的升高可能是高血压的始动因素;发现IR、血浆中AngⅡ及CGRP水平升高的有高血压家族史的健康子女,可能是高血压的高危对象,应积极采取一级预防措施防止高血压的发生。 Objective To study the changes of insulin resistance (IR) and the plasma levels of AngⅡ and CGRP in healthy children with a family history of essential hypertension (EH) and explore their effects on pathogenesis of EH and significance of its first-level prevention. Methods Sixty healthy people with a family history of EH were recruited and randomized to two groups: 30 with one parent (group A) and 30 with both parents (group B) had a history of EH, and 30 subjects without a family history of EH as controls (group C). FINS, plasma AngⅡ and CGRP were determined by radioimmunoassay, and IRI calculated. Results The levels of IR, AngⅡ and CGRP increased significantly in groups A and B compared with those in the control (F= 14.43-16.63 ,q= 6.48-8.15, P〈0.01). Plasma AngⅡ and CGRP were higher in subjects in group B than that in group A (F= 15.14,16.63;q= 3.12,3.98;P〈0.05). CGRP was positively correlated with AngⅡ in both groups A and B (r=0. 682, P〈 0.01). Conclusion The higher levels of IR and plasma AngⅡ and CGRP may exist before the development of hypertension in healthy offspring with a family history of EH, the above items are regarded as initiating agents of EH. People with IR and high levels of plasma AngⅡ and CGRP with a family history of ED are at high risk to have hypertension, a primary prevention should be offered to them.
出处 《青岛大学医学院学报》 CAS 2009年第2期148-150,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 高血压 胰岛素抵抗 降钙素基因相关肽 血管紧张素Ⅱ 家族史 Hypertension Insulin resistances Calcitonin gene-related peptide Angiotensin Ⅱ Family history
  • 相关文献

参考文献9

二级参考文献19

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2谭敦勇,姚兴海,赵东,汤健,唐朝枢.降钙素基因相关肽对内皮素释放的影响[J].中国病理生理杂志,1994,10(5):545-547. 被引量:49
  • 3王敏霞,杜学海.慢性肾衰患者血浆心房肽水平与血容量及肾素—血管紧张素II...[J].中华肾脏病杂志,1989,5(5):271-274. 被引量:2
  • 4[1]Borghi C, Costa FV, Boschi S, et al. Factors associated with the development of stable hypertension in your borderline hypertensives[J]. J hypertens, 1996, Apr, 14(4):509-517
  • 5[2]孙宁铃,等主编.今日高血压.北京:中国医药科技出版社,1999:9
  • 6[3]Corol P,Soubrier F,Jeunermitre X. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension. Path Biol, 1997,45: 229-239
  • 7[4]Rotimi C, Cooper R, Ogumbiyi O, et al. Hypertension and serum angiotensin -nogen and molecular variants of the angiotension gene among nigerians. Circulation , 1997,95 : 2348-2350
  • 8[5]Soubrier F, Albence GF, Herbeth B, et al. Two putative Active Genters in Human Angiotensin I cloning [J]. ProcNatl Acad Sci USA, 1988,859(24): 9386-9390
  • 9[7]Taddei S, Virdis A, Mattei P, et al. Defective L-Arginine-Nitri Oxide pathway in offspring of essential hypertensive patients .Circulation, 1996; 94:1298
  • 10[8]Vanhoutte PM, Boulanger CM, Mombouli JV. Endothelium-derived relaxing factors and converting enzyme inhibition. AM J Cardiol, 1995; 76: 3

共引文献386

同被引文献29

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部